May NCI Office of Advocacy Relations Update

National Cancer Institute sent this bulletin at 05/05/2020 04:11 PM EDT
National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

 

 

You are subscribed to the Office of Advocacy Relations Update from the National Cancer Institute. Read highlights of the latest news and upcoming events happening at NCI. 

 

The NCI remains committed to working with advocates during this time. Although we are all working remotely, we continue to work with advocates every day. To reach out to the Office of Advocacy Relations, please email nciadvocacy@nih.gov and a staff member will be in touch shortly.

 

COVID-19 NCI News and Resources

At NCI, A Robust and Rapid Response to the COVID-19 Pandemic by Norman E. Sharpless, M.D.

NCI is lending its tremendous expertise and unique research capabilities to the global response to the COVID-19 pandemic. NCI Director Dr. Norman Sharpless describes some of the COVID-19 specific research activities NCI has initiated.

 

NCI Activities: COVID-19 and Cancer Research (AACR Presentation Video)

At the AACR Virtual Meeting, Dr. Dinah Singer presented about the impact of the COVID-19 pandemic on NCI and the extramural community and gave an overview of NCI’s efforts to contribute to the COVID-19 crisis. Dr. Singer also provided some details on how NCI, working with NIH, has implemented new flexibilities for the cancer research community during this crisis. 

 

NCI Part of Federal Effort to Evaluate Antibody Tests for Novel Coronavirus 

NCI scientists, along with experts from other government agencies and academic medical centers, have launched a joint effort to help FDA evaluate commercially available antibody tests for SARS-CoV-2, the coronavirus that causes COVID-19.

 

Coronavirus: What People with Cancer Should Know (UPDATED)

This NCI page provides guidance and resources for cancer patients regarding COVID-19.

 

Upcoming Events

Virtual Board of Scientific Advisors (BSA) Meeting, May 12, 2020

Recent Cancer Currents Posts

  

Helping Cancer Survivors Cope with Cancer-Related Anxiety and Distress (April 30, 2020)

Researchers are exploring ways to support the psychological and emotional needs of cancer survivors and how to tailor existing approaches to meet the needs of specific individuals or groups.

 

NCI Initiative Aims to Boost CAR T-Cell Therapy Clinical Trials (April 23, 2020)

NCI is developing the capability to produce cellular therapies, like CAR T cells, to be tested in cancer clinical trials at multiple hospital sites. Few laboratories and centers have the capability to make CAR T cells, which has limited the ability to test them more broadly.

 

Deaths from Metastatic Melanoma Drop Substantially in the United States (April 21, 2020)

After rising steadily for decades, the number of people in the United States who die each year from the skin cancer melanoma has dramatically dropped in recent years, results from a new study show. Learn what has contributed to the dramatic decline.

 

Single Dose of HPV Vaccine Yields Long-Term Protection from Many Cancer-Causing Types (April 10, 2020)

More than a decade after vaccination, women who had received a single dose of the HPV vaccine continued to be protected against infection with the two cancer-causing HPV types targeted by the vaccine, an NCI-funded clinical trial shows.

 

Women Experience More Side Effects from Pelvic Radiation than Realized (April 8, 2020)

Women with cervical or uterine cancer who received radiation to the pelvic region reported side effects much more often using an online reporting system called PRO-CTCAE than they did during conversations with their clinicians, a new study shows.

 

Read more news at the Cancer Currents blog.